m6A methylation and its enzyme METTL3 are upregulated in glioblastoma stem cells and HCC, and the high expression of METTL3 induces SOCS2 degradation by m6A methylation, thus promoting tumor cell growth and survival [27]. The gene discussed is SOCS2; the disease is neoplasm.